Connection

IVAN ROSAS to Disease Progression

This is a "connection" page, showing publications IVAN ROSAS has written about Disease Progression.
Connection Strength

0.881
  1. Development, Progression, and Mortality of Suspected Interstitial Lung Disease in COPDGene. Am J Respir Crit Care Med. 2024 Dec 15; 210(12):1453-1460.
    View in: PubMed
    Score: 0.145
  2. Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases. Respir Res. 2021 Mar 16; 22(1):84.
    View in: PubMed
    Score: 0.112
  3. Development and Progression of Interstitial Lung Abnormalities in the Framingham Heart Study. Am J Respir Crit Care Med. 2016 12 15; 194(12):1514-1522.
    View in: PubMed
    Score: 0.083
  4. Update in diffuse parenchymal lung disease, 2013. Am J Respir Crit Care Med. 2015 Feb 01; 191(3):270-4.
    View in: PubMed
    Score: 0.073
  5. The expanding role of biomarkers in the assessment of smoking-related parenchymal lung diseases. Chest. 2012 Oct; 142(4):1027-1034.
    View in: PubMed
    Score: 0.062
  6. Subclinical interstitial lung disease: why you should care. Am J Respir Crit Care Med. 2012 Jun 01; 185(11):1147-53.
    View in: PubMed
    Score: 0.060
  7. Automated quantification of high-resolution CT scan findings in individuals at risk for pulmonary fibrosis. Chest. 2011 Dec; 140(6):1590-1597.
    View in: PubMed
    Score: 0.057
  8. Progressive preclinical interstitial lung disease in rheumatoid arthritis. Arch Intern Med. 2008 Jan 28; 168(2):159-66.
    View in: PubMed
    Score: 0.045
  9. Visual and Quantitative Interstitial Lung Abnormality Progression in COPDGene. Am J Respir Crit Care Med. 2025 Oct; 211(10):1794-1801.
    View in: PubMed
    Score: 0.038
  10. Early immune factors associated with the development of post-acute sequelae of SARS-CoV-2 infection in hospitalized and non-hospitalized individuals. Front Immunol. 2024; 15:1348041.
    View in: PubMed
    Score: 0.034
  11. Progressive Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis. Am J Respir Crit Care Med. 2023 01 15; 207(2):211-214.
    View in: PubMed
    Score: 0.032
  12. The lung microbiome in end-stage Lymphangioleiomyomatosis. Respir Res. 2021 Oct 26; 22(1):277.
    View in: PubMed
    Score: 0.029
  13. Detection and Early Referral of Patients With Interstitial Lung Abnormalities: An Expert Survey Initiative. Chest. 2022 02; 161(2):470-482.
    View in: PubMed
    Score: 0.029
  14. Baseline Characteristics and Progression of a Spectrum of Interstitial Lung Abnormalities and Disease in Rheumatoid Arthritis. Chest. 2020 10; 158(4):1546-1554.
    View in: PubMed
    Score: 0.026
  15. Imaging Patterns Are Associated with Interstitial Lung Abnormality Progression and Mortality. Am J Respir Crit Care Med. 2019 07 15; 200(2):175-183.
    View in: PubMed
    Score: 0.025
  16. B Cell-Activating Factor. An Orchestrator of Lymphoid Follicles in Severe Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2015 Sep 15; 192(6):695-705.
    View in: PubMed
    Score: 0.019
  17. Impairment of alveolar macrophage transcription in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2007 Jun 01; 175(11):1151-7.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.